In this episode, Beatriz Aguirre—an accomplished leader based in Spain with over 20 years of experience in the pharmaceutical industry—shares insights on building thriving, people-first workplaces. With a track record of leading international teams, Beatriz explores how a human-centric approach to leadership can transform organizational culture, elevate service quality, and drive financial performance. Listeners will gain practical strategies for fostering environments where individuals grow both professionally and personally. Tune in for a compelling conversation on the power of empathy, purpose, and authentic leadership in today’s evolving business landscape.

Episode 27: How Genuine People Care Drives Business Success

In this episode, Mélanie Pomerleau, Vice President of Quality and Compliance at Indero, joins us to explore the upcoming ICH E6 (R3) guideline revision. With over 25 years in the pharmaceutical and biotech industries, Mélanie shares expert insights on key changes, including the restructured document format, modernized GCP principles, enhanced patient centricity, and the integration of decentralized and adaptive trial designs. We also discuss evolving regulatory expectations, audit trends, and the growing importance of data governance. Tune in to understand how sponsors, CROs, and sites can prepare for the July 2025 implementation and navigate this transition. 

Episode 28: What is New With ICH E6 (R3)?

In the Season 3 finale of Phase Forward, clinical research veterans Ted Trafford and Brad Hightower share essential insights on building stronger collaborations between sponsors, CROs, and clinical trial sites. Drawing from decades of hands-on experience, they explore how sustained site motivation, protocol clarity, and fair financial practices directly impact study success. Ted, who expanded Probity Medical Research into a global network, and Brad, founder of Hightower Clinical and host of Note to File, offer practical strategies and real-world examples. This 3-part series is a must-listen for sponsors seeking to elevate site relationships and drive more efficient, effective trials.

Episode 29: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 1: Site Engagement

Episode 30: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 2: Focus on Protocol

Episode 31: Dos and Don'ts for Sponsors and CROs in Site Collaborations – Part 3: Payments

In this episode, Sarah Ballard, Agency Director at KDM, dives into the strategic power of PR in navigating the complex world of scientific and clinical communications. With over 20 years in B2B marketing, Sarah reveals how public relations drives trust and credibility amid digital disruption and stringent regulations. Explore how value-driven storytelling aligns with business growth, stakeholder expectations, and investor confidence. The episode also unpacks real-world challenges like reputation fragility, AI’s role in content creation, and the necessity of human nuance.

Episode 32: Strategic Storytelling: The Role of PR in Biotech & Pharma Stakeholder Engagement

In this episode, Isabel Dorion, Senior Director of Clinical Operations at Indero, shares expert insights on the critical role of Clinical Research Associates (CRAs) in ensuring trial quality and patient safety. Explore key strategies for effective CRA oversight and discover how quality reviews and adaptive risk-based monitoring enhance compliance and data integrity. Tune in for practical guidance on maintaining excellence in clinical monitoring and elevating trial outcomes.

Episode 34: Elevating Clinical Research Associate Oversight for Quality and Impact

In this episode of Phase Forward, Dr. Ana Palijan explores how early phase clinical trials have evolved beyond their traditional safety focus. With over 25 years in translational research, she discusses the growing complexity driven by scientific advances, technology integration, and global trial execution. Dr. Palijan highlights the shift toward context-specific strategies, the double-edged role of digital systems, and the rising value of niche CROs. She also examines the operational challenges faced by small biotech companies and the importance of aligning trial design with study intent. Tune in for a deep dive into the future of early clinical development.

Episode 33: Beyond Safety: The Evolving Complexity of Early Phase Studies

In this episode of Phase Forward, Hubert Godziatkowski, founder of the Polish Atopic Disease Association (PTCA), shares how patient organizations can reshape clinical trials. With over 800,000 people in Poland affected by atopic dermatitis, PTCA is working to improve clarity in consent forms, promote ethical oversight, and build trust between sponsors and patients. The conversation explores PTCA's review of consent forms, the importance of early collaboration, and the role of advocacy groups in improving recruitment and trial accessibility.

Episode 35: PTCA – Speaking the Same Language:  How Patient Organizations and Sponsors Can Align in Clinical Trials

In this episode of Phase Forward, Siow Bee Seu, Director of Clinical Operations for APAC at Indero, shares her perspective on the evolving clinical trial landscape across the APAC region. With nearly 2 decades of experience in clinical research, she offers valuable insights into the strategic importance of APAC in global trials. Drawing from her expertise in project operations, regulatory strategy, and team leadership, Siow discusses how clinical trial approaches must adapt to the unique contexts of individual countries while navigating the region’s complex regulatory environment. Her reflections provide a practical look at managing trials in one of the world’s most dynamic regions.

Episode 36: Clinical Trials Across Asia

Phase Forward: Your Gateway to Dermatology and Rheumatology Clinical Research
Dive into the world of dermatology and rheumatology clinical research with Phase Forward, the podcast that brings you the latest insights, innovations, and expert advice. Powered by Indero, a leading full-service CRO, this podcast is your go-to source for everything you need to know about managing and conducting clinical trials in these fields.
Each episode features engaging interviews, thought-provoking discussions, and captivating stories from the forefront of clinical research. Whether you are a sponsor, investigator, or study coordinator, you will find valuable information and practical tips to enhance your work.
Stay ahead of the curve with updates on the newest advancements in trial design and methodology, and gain a deeper understanding of the processes and considerations in clinical research.
Don't miss out—subscribe now and join the conversation on dermatology and rheumatology clinical research with Phase Forward!

Episode 28: What is New With ICH E6 (R3)?

Phase Forward

Related tracks